期刊文献+

星形细胞肿瘤中端粒酶与PTEN的表达及相关性 被引量:3

Relationship between telomerase and PTEN expression in astrocytoma
下载PDF
导出
摘要 目的 :研究星形细胞肿瘤中的端粒酶活性和PTEN表达 ,探讨其在星形细胞肿瘤发生发展过程中的相关性。方法 :收集手术切除经病理证实的星形细胞肿瘤 110例 ,8例正常脑组织作对照。用端粒酶原位杂交检测盒检测组织标本端粒酶活性。用LSAB法检测PTEN表达。结果 :星形细胞肿瘤端粒酶活性和PTEN的阳性检出率分别为 5 0 % (5 5 / 110 )和 39 1%(4 3/ 110 )。且随着肿瘤恶性程度的增加 ,端粒酶活性程度升高 (P <0 0 1)。端粒酶活性与PTEN表达有相关性 (P <0 0 1)。结论 :端粒酶活性与星形细胞肿瘤的分化程度有关 ,提示端粒酶活性可能是星形细胞肿瘤恶性程度的重要标记物 。 Purpose To study the telomerase activity and expression of PTEN protein in astrocytoma and to investigate their relations during histogenesis and development of astrocytoma. Methods Totally 110 cases of astrocytoma tissues and 8 normal brain tissues were studied. The telomerase activity was detected using telomerase ISH detection Kit. PTEN protein was detected by immunohistochemical LSAB method. Results The positive staining rates of telomerase and PTEN protein in astrocytoma were 50%(55/110) and 39 1% (43/110) respectively. Expression of telomerase was positively correlated with the malignant degree of astrocytomas ( P <0 01). Telomerase activity was associated with PTEN expression in astrocytomas ( P <0 01). Conclusions Telomerase activity correlates with the degree of the neoplastic differentiation, and may be an important marker for the malignancy of astrocytoma. PTEN may affect telomerase activity.
出处 《临床与实验病理学杂志》 CAS CSCD 2001年第6期496-498,共3页 Chinese Journal of Clinical and Experimental Pathology
关键词 星形细胞瘤 端粒 末端转移酶 PTEN蛋白 astrocytoma telomerase PTEN protein
  • 相关文献

参考文献2

  • 1Wang S I,Cancer Res,1998年,57卷,4183页
  • 2Li J,Science,1997年,275卷,1943页

同被引文献43

  • 1Ambrosini G, Adida C, Ahieri DC. A novel anti-apoptosis gene Survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-921.
  • 2Suzuki A, In T, Kawano H, et al. Survivin initiates procaspase3/p21 complex formation as a result of interaction with CDK4 to resist Fas-mediated cell death. Oncogene 2000; 19:1346-1353.
  • 3Harfouche R, Hassessian. HM, Guo Y, et al. Mechanisms which mediated the antiapoptotic effectes of angiopoietin-1 on endothelial cells. Microvasc Res 2002;64:135-147.
  • 4Lo Muzio L, Staibano S, Pannone G, et al. Expreesion of the apoptosis inhibitor Survivin in aggresive squamous cell carcinoma.Exp Mol Pathol 2001 ;70:249-254.
  • 5Chiodino C, Cesinaro AM, Ottani D, et al. Communication: expression of the novel inhibitor of apoptosis Survivin in normal and neoplastic skin. J Invest Dermatol 1999; 113:415-418.
  • 6Del Pizzo TJ, Borkowski A, Jacobs SC, et al. Loss of cell cyclic regulaters p27kipl and cyclin E in transitional bladder correlates with tumor grade and patient suvival. Am J Pathol 1999;155:1129-1136.
  • 7Newcomb EW, Sosnow M, Demopoulos RI, et al. Expression of the cell cycle inhibitor p27kipl is a new prognostic marker associated with survival in epithelial ovarian tumors. American Journal of Pathology 1999;154:119-125.
  • 8Kondo K, Yao M, Kobayaski K, et al. P-FEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell live. Int J Cancer 2001;91:219-224.
  • 9Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275: 1943-1947.
  • 10Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at. chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet, 1997, 15:356-362.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部